Stock analysts at StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in a research report issued on Friday. The firm set a “hold” rating on the stock.
Brooklyn ImmunoTherapeutics Stock Performance
Shares of NYSE:BTX opened at $0.44 on Friday. The firm has a fifty day moving average price of $0.46 and a 200 day moving average price of $1.13. Brooklyn ImmunoTherapeutics has a fifty-two week low of $0.17 and a fifty-two week high of $10.10. The firm has a market cap of $25.64 million, a price-to-earnings ratio of -0.19 and a beta of 4.61.
About Brooklyn ImmunoTherapeutics
See Also
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- How Technical Indicators Can Help You Find Oversold Stocks
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Compound Interest and Why It Matters When Investing
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- How to Most Effectively Use the MarketBeat Earnings Screener
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
